Photodynamic therapy in superficial bladder cancer: past, present and future

Détails

ID Serval
serval:BIB_9A0C9D0F6013
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Photodynamic therapy in superficial bladder cancer: past, present and future
Périodique
Urological Research
Auteur(s)
Jichlinski  P., Leisinger  H. J.
ISSN
0300-5623
Statut éditorial
Publié
Date de publication
12/2001
Peer-reviewed
Oui
Volume
29
Numéro
6
Pages
396-405
Notes
Journal Article
Research Support, Non-U.S. Gov't
Review --- Old month value: Dec
Résumé
For many reasons, such as toxicity and lack of selectivity of photosensitisers, as well as complexity of technical procedures and inconstant therapeutic results, photodynamic therapy of highly recurrent superficial bladder cancer never gained wide acceptance in the urological community. However, the 25 years of experience combined with the recent discovery of new photosensitisers, such as protoporphyrin IX (PpIX) induced by 5-aminolevulinic acid (ALA) or ALA-derivatives or hypericin open new, very interesting perspectives in this therapeutic field.
Mots-clé
Humans Photochemotherapy/*trends Urinary Bladder Neoplasms/*drug therapy/physiopathology
Pubmed
Web of science
Création de la notice
21/01/2008 16:09
Dernière modification de la notice
20/08/2019 15:01
Données d'usage